 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Laura Helmkamp and Daniel Matlock.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.646 |
|
|
|
-
Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
Score: 0.172
-
Wallace BC, Allen LA, Knoepke CE, Glasgow RE, Lewis CL, Fairclough DL, Helmkamp LJ, Fitzgerald MD, Tzou WS, Kramer DB, Varosy PD, Gupta SK, Mandrola JM, Brancato SC, Peterson PN, Matlock DD. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data. Am Heart J. 2020 08; 226:161-173.
Score: 0.166
-
Canty GA, Helmkamp L, Leslie SE, Vemuru S, Adams M, Higgins MG, Davis RA, Scherer LD, Baurle E, Matlock DD, Lee C, Tevis S. Evaluation of visual displays to share expected quality of life changes with patients with breast cancer. Surgery. 2025 Dec; 188:109770.
Score: 0.060
-
Higgins MG, Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Christian N, Ahrendt G, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Access to results of patient reported outcome surveys did not improve longitudinal patient reported outcomes in breast cancer patients in a randomized controlled trial. Am J Surg. 2025 Jan; 239:116054.
Score: 0.057
-
Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Higgins M, Christian N, Ahrendt G, Baurle E, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2024 Oct; 31(11):7597-7606.
Score: 0.056
-
Lipsey J, Allen LA, Page RL, Helmkamp LJ, Venechuk G, Trinkley KE, Matlock DD, McIlvennan CK. Association of multimorbidity with guideline-directed medical therapy intensification in heart failure: Findings from the EPIC-HF trial. Heliyon. 2024 Jul 15; 10(13):e34178.
Score: 0.055
-
Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
Score: 0.042
-
McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant. 2019 04; 38(4):374-381.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|